Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (375) 375
Newspaper Article (81) 81
Patent (35) 35
Book Chapter (16) 16
Book / eBook (4) 4
Trade Publication Article (3) 3
Conference Proceeding (2) 2
Book Review (1) 1
Dissertation (1) 1
Magazine Article (1) 1
Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (251) 251
life sciences & biomedicine (203) 203
humans (182) 182
respiratory system (131) 131
female (105) 105
male (102) 102
general & internal medicine (97) 97
abridged index medicus (90) 90
middle aged (89) 89
aged (79) 79
critical care medicine (77) 77
pulmonary fibrosis (70) 70
biological and medical sciences (65) 65
diagnosis (65) 65
medical sciences (52) 52
adult (46) 46
idiopathic pulmonary fibrosis (45) 45
lung diseases (41) 41
surgery (36) 36
disease progression (35) 35
identification (34) 34
human necessities (33) 33
hygiene (33) 33
medical or veterinary science (33) 33
prognosis (33) 33
physical sciences (32) 32
treatment outcome (32) 32
animals (31) 31
astronomy & astrophysics (31) 31
research (31) 31
biopsy (29) 29
pneumology (29) 29
tomography, x-ray computed (29) 29
idiopathic pulmonary fibrosis - physiopathology (28) 28
patients (27) 27
fibrosis (26) 26
respiratory tract diseases (26) 26
interstitial lung disease (25) 25
analysis (24) 24
astrophysics (24) 24
idiopathic pulmonary fibrosis - drug therapy (24) 24
lung - pathology (23) 23
galaxy astrophysics (22) 22
idiopathic pulmonary fibrosis - diagnosis (22) 22
carbon monoxide (21) 21
earth and planetary astrophysics (21) 21
astrophysics - solar and stellar astrophysics (20) 20
astrophysics, cosmology and astronomy (20) 20
care and treatment (20) 20
medicine, general & internal (20) 20
mortality (20) 20
pneumonia (20) 20
retrospective studies (20) 20
clinical trials (19) 19
diagnosis, differential (19) 19
respiratory function tests (19) 19
aged, 80 and over (18) 18
idiopathic pulmonary fibrosis - pathology (18) 18
accretion disks (17) 17
anesthesia. intensive care medicine. transfusions. cell therapy and gene therapy (17) 17
intensive care medicine (17) 17
lung - physiopathology (17) 17
solar and stellar astrophysics (17) 17
cosmology and extragalactic astrophysics (16) 16
drug therapy (16) 16
melanoma - drug therapy (16) 16
mice (16) 16
multidisciplinary sciences (16) 16
oncology (16) 16
science & technology - other topics (16) 16
severity of illness index (16) 16
stars (16) 16
stars: pre-main sequence (16) 16
lung - diagnostic imaging (15) 15
physics (15) 15
predictive value of tests (15) 15
pulmonary/respiratory (15) 15
thompson, tommy g (15) 15
usage (15) 15
usual interstitial pneumonia (15) 15
devices for introducing media into, or onto, the body (14) 14
devices for producing or ending sleep or stupor (14) 14
devices for transducing body media or for taking media fromthe body (14) 14
follow-up studies (14) 14
fundamental and applied biological sciences. psychology (14) 14
indoles - therapeutic use (14) 14
investigating or analysing materials by determining theirchemical or physical properties (14) 14
lung diseases, interstitial - pathology (14) 14
measuring (14) 14
melanoma - genetics (14) 14
physics - solar and stellar astrophysics (14) 14
protoplanetary disks (14) 14
testing (14) 14
gene expression (13) 13
lung diseases, interstitial - diagnosis (13) 13
lungs (13) 13
medical prognosis (13) 13
nonspecific interstitial pneumonia (13) 13
prospective studies (13) 13
proto-oncogene proteins b-raf - genetics (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Diagnosis of idiopathic pulmonary fibrosis An Official ATS/ERS/JRS/ALAT Clinical practice guideline
by Raghu, Ganesh and Remy-Jardin, Martine and Myers, Jeffrey L and Richeldi, Luca and Ryerson, Christopher J and Lederer, David J and Behr, Juergen and Cottin, Vincent and Danoff, Sonye K and Morell, Ferran and Flaherty, Kevin R and Wells, Athol and Martinez, Fernando J and Azuma, Arata and Bice, Thomas J and Bouros, Demosthenes and Brown, Kevin K and Collard, Harold R and Duggal, Abhijit and Galvin, Liam and Inoue, Yoshikazu and Gisli Jenkins, R and Johkoh, Takeshi and Kazerooni, Ella A and Kitaichi, Masanori and Knight, Shandra L and Mansour, George and Nicholson, Andrew G and Pipavath, Sudhakar N.J and Buendía-Roldán, Ivette and Selman, Moisés and Travis, William D and Walsh, Simon and Wilson, Kevin C and European Resp Soc and Latin American Thoracic Soc and Japanese Resp Soc and American Thoracic Soc and American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society
American journal of respiratory and critical care medicine, ISSN 1073-449X, 09/2018, Volume 198, Issue 5, pp. e44 - e68
Interstitial lung disease | Idiopathic pulmonary fibrosis | Pulmonary fibrosis | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Pneumonia | Biopsy | Lung diseases | Quality | Tomography | Systematic review | Adults | Clinical medicine | Surfactants | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Idiopathic pulmonary fibrosis: Clinically meaningful primary endpoints in phase 3 clinical trials
by Raghu, Ganesh and Collard, Harold R and Anstrom, Kevin J and Flaherty, Kevin R and Fleming, Thomas R and King Jr, Talmadge E and Martinez, Fernando J and Brown, Kevin K
American journal of respiratory and critical care medicine, ISSN 1073-449X, 05/2012, Volume 185, Issue 10, pp. 1044 - 1048
Endpoints | Clinical trials | Surrogate endpoints | Survival | Idiopathic pulmonary fibrosis | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Intensive care medicine | Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Pneumology | Severity of Illness Index | Humans | Endpoint Determination - methods | Respiratory System Agents - therapeutic use | Treatment Outcome | Hospitalization | Clinical Trials, Phase III as Topic - methods | Idiopathic Pulmonary Fibrosis - surgery | Lung Transplantation | Idiopathic Pulmonary Fibrosis - mortality | Survival Analysis | Biomarkers | Idiopathic Pulmonary Fibrosis - drug therapy | Index Medicus | Abridged Index Medicus | endpoints | clinical trials | idiopathic pulmonary fibrosis | Pulmonary | surrogate endpoints | survival
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis
by Brown, Kevin K and Flaherty, Kevin R and Cottin, Vincent and Raghu, Ganesh and Inoue, Yoshikazu and Azuma, Arata and Huggins, John T and Richeldi, Luca and Stowasser, Susanne and Stansen, Wibke and Schlenker-Herceg, Rozsa and Maher, Toby M and Wells, Athol U
Respiratory medicine, ISSN 0954-6111, 01/2019, Volume 146, pp. 42 - 48
Protein-tyrosine kinases | Vital capacity | Interstitial lung diseases | Pulmonary gas exchange | Respiratory function tests | Cardiac & Cardiovascular Systems | Respiratory System | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Forced Expiratory Volume - drug effects | Humans | Middle Aged | Respiratory Function Tests - methods | Male | Treatment Outcome | Lung - physiopathology | Oximetry - methods | Disease Progression | Indoles - administration & dosage | Vital Capacity - drug effects | Protein Kinase Inhibitors - administration & dosage | Idiopathic Pulmonary Fibrosis - diagnosis | Protein Kinase Inhibitors - therapeutic use | Lung - drug effects | Pulmonary Gas Exchange - drug effects | Female | Indoles - therapeutic use | Aged | Idiopathic Pulmonary Fibrosis - physiopathology | Idiopathic Pulmonary Fibrosis - drug therapy | Placebos - administration & dosage | Fees & charges | Diffusion rate | Respiratory function | Mortality | Lung diseases | Saturation | Oximetry | Advisors | Clinical trials | Oxygen content | Patients | Subgroups | Rangefinding | Manuscripts | Pulmonary fibrosis | Fibrosis | Fibroblasts | Carbon monoxide | Growth factors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
by Flaherty, Kevin R and Wells, Athol U and Cottin, Vincent and Devaraj, Anand and Walsh, Simon L.F and Inoue, Yoshikazu and Richeldi, Luca and Kolb, Martin and Tetzlaff, Kay and Stowasser, Susanne and Coeck, Carl and Clerisme-Beaty, Emmanuelle and Rosenstock, Bernd and Quaresma, Manuel and Haeufel, Thomas and Goeldner, Rainer-Georg and Schlenker-Herceg, Rozsa and Brown, Kevin K and INBUILD Trial Investigators
The New England journal of medicine, ISSN 0028-4793, 10/2019, Volume 381, Issue 18, pp. 1718 - 1727
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Humans | Middle Aged | Male | Protein Kinase Inhibitors - adverse effects | Diarrhea - chemically induced | Disease Progression | Vital Capacity - drug effects | Indoles - adverse effects | Protein Kinase Inhibitors - therapeutic use | Female | Indoles - therapeutic use | Aged | Idiopathic Pulmonary Fibrosis - physiopathology | Idiopathic Pulmonary Fibrosis - drug therapy | Drug therapy | Lung diseases, Interstitial | Patient outcomes | Tyrosine | Genotype & phenotype | Computed tomography | Technical communication | Lung diseases | Questionnaires | Fibrosis | Diarrhea | Carbon monoxide | Patients | Population decline | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
by Richeldi, Luca and du Bois, Roland M and Raghu, Ganesh and Azuma, Arata and Brown, Kevin K and Costabel, Ulrich and Cottin, Vincent and Flaherty, Kevin R and Hansell, David M and Inoue, Yoshikazu and Kim, Dong Soon and Kolb, Martin and Nicholson, Andrew G and Noble, Paul W and Selman, Moisés and Taniguchi, Hiroyuki and Brun, Michèle and Le Maulf, Florence and Girard, Mannaïg and Stowasser, Susanne and Schlenker-Herceg, Rozsa and Disse, Bernd and Collard, Harold R and INPULSIS Trial Investigators
The New England journal of medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 22, pp. 2071 - 2082
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Enzyme Inhibitors - adverse effects | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Protein Kinase Inhibitors - adverse effects | Disease Progression | Indoles - administration & dosage | Enzyme Inhibitors - administration & dosage | Vital Capacity - drug effects | Protein Kinase Inhibitors - administration & dosage | Indoles - adverse effects | Quality of Life | Female | Aged | Idiopathic Pulmonary Fibrosis - physiopathology | Idiopathic Pulmonary Fibrosis - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Complications and side effects | Dosage and administration | Pulmonary fibrosis | Research | Drug therapy | Anti-arrhythmia drugs | Tyrosine | Respiratory function | Biopsy | Lung diseases | Fibrosis | Clinical trials | Diarrhea | Vascular endothelial growth factor | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Acute exacerbation of idiopathic pulmonary fibrosis an international working group report
by Collard, Harold R and Ryerson, Christopher J and Corte, Tamera J and Jenkins, Gisli and Kondoh, Yasuhiro and Lederer, David J and Lee, Joyce S and Maher, Toby M and Wells, Athol U and Antoniou, Katerina M and Behr, Juergen and Brown, Kevin K and Cottin, Vincent and Flaherty, Kevin R and Fukuoka, Junya and Hansell, David M and Johkoh, Takeshi and Kaminski, Naftali and Kim, Dong Soon and Kolb, Martin and Lynch, David A and Myers, Jeffrey L and Raghu, Ganesh and Richeldi, Luca and Taniguchi, Hiroyuki and Martinez, Fernando J
American journal of respiratory and critical care medicine, ISSN 1073-449X, 08/2016, Volume 194, Issue 3, pp. 265 - 275
Pulmonary fibrosis | Diagnosis | Management | Review | Acute exacerbation | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Idiopathic Pulmonary Fibrosis - epidemiology | Idiopathic Pulmonary Fibrosis - therapy | Acute Disease | Prognosis | Internationality | Humans | Risk Factors | Disease Management | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Lung function outcomes in the INPULSIS.sup.[R] trials of nintedanib in idiopathic pulmonary fibrosis
by Brown, Kevin K and Flaherty, Kevin R and Cottin, Vincent and Raghu, Ganesh and Inoue, Yoshikazu and Azuma, Arata and Huggins, John T and Richeldi, Luca and Stowasser, Susanne and Stansen, Wibke and Schlenker-Herceg, Rozsa and Maher, Toby M and Wells, Athol U
Respiratory medicine, ISSN 0954-6111, 01/2019, Volume 146, p. 42
Pulmonary fibrosis | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. What's in a name? That which we call IPF, by any other name would act the same
by Wells, Athol U and Wells, Athol U and Brown, Kevin K and Brown, Kevin K and Flaherty, Kevin R and Kolb, Martin and Thannickal, Victor J and IPF Consensus Working Grp and IPF Consensus Working Group
The European respiratory journal, ISSN 0903-1936, 05/2018, Volume 51, Issue 5, pp. 1800692 - 1800692
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Phenotype | History, 21st Century | History, 20th Century | Humans | Terminology as Topic | Idiopathic Pulmonary Fibrosis - history | Idiopathic Pulmonary Fibrosis - physiopathology | Idiopathic Pulmonary Fibrosis - classification | Disease Progression | Clinical trials | Translation | Phenotypes | Nomenclature | Lung diseases | Fibrosis
Journal Article
Details down arrow
9. Full Text Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
by Richeldi, Luca and Costabel, Ulrich and Selman, Moises and Kim, Dong Soon and Hansell, David M and Nicholson, Andrew G and Brown, Kevin K and Flaherty, Kevin R and Noble, Paul W and Raghu, Ganesh and Brun, Michèle and Gupta, Abhya and Juhel, Nolwenn and Klüglich, Matthias and du Bois, Roland M
The New England journal of medicine, ISSN 0028-4793, 09/2011, Volume 365, Issue 12, pp. 1079 - 1087
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Enzyme Inhibitors - adverse effects | Humans | Middle Aged | Male | Alanine Transaminase - blood | Enzyme Inhibitors - therapeutic use | Vital Capacity | Indoles - adverse effects | Aspartate Aminotransferases - blood | Liver - drug effects | Adult | Female | Indoles - therapeutic use | Aged | Idiopathic Pulmonary Fibrosis - physiopathology | Idiopathic Pulmonary Fibrosis - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Tyrosine | Dosage and administration | Pulmonary fibrosis | Drug therapy | Patient outcomes | Respiratory function | Statistical analysis | Writers | Disease | Liver | Lung diseases | Quality of life | Fibrosis | Clinical medicine | Growth factors | Protein-tyrosine kinase | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights